Skip to content

Identifying the Anti-Blood-Clotting Compounds in Garlic

Identification of the Antiplatelet Compounds of Garlic Ex Vivo

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00200785
Enrollment
9
Registered
2005-09-20
Start date
2006-03-31
Completion date
2007-09-30
Last updated
2010-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arteriosclerosis, Intracranial Arteriosclerosis

Keywords

garlic

Brief summary

This study will seek to identify the compound(s) in garlic that is (are) responsible for its ability to prevent the formation of blood clots (prevent platelet aggregation) and to determine the maximally effective dose and duration of the benefits. This study will also determine whether cooked garlic (garlic powder added to boiling water, no allicin present) is as effective as fresh garlic (garlic powder added to ambient water, high allicin present) and, if more than one compound is involved, and whether their combined effects are more significant than the effects of each compound alone.

Detailed description

Published studies indicate that various types of undefined garlic products display antiplatelet activity. However, the compounds responsible for this antiplatelet effect have not been identified. Acute studies. In acute (one day) studies, healthy participants will consume several doses of fresh garlic (garlic powder added to ambient water; up to the equivalent of 12 grams fresh garlic or 52 mg allicin) as a paste in a tuna sandwich. At 0, 2, 4, and 6 hours after consumption, the ability of platelets to aggregate in platelet-rich plasma (PRP) or in whole blood (WB), in response to a drug (collagen, ADP) that stimulates platelet aggregation, will be measured. After establishing the optimum dose and optimum time of the antiplatelet effect for each person, and if the effects are sufficiently strong, the effects of cooked garlic (garlic powder added to boiling water, no allicin present) and seven extracted fractions (oil, protein, fructans, etc.) will be determined, using the fractions at the same dose as their abundance in the established optimum dose of crushed fresh garlic. Chronic studies. If only weak platelet effects are found for a high acute dose of fresh garlic, chronic studies will be conducted. In chronic studies, participants will consume 8.0 grams of fresh garlic (2.7 grams garlic powder added to ambient water, allicin content = 35 mg) as a paste in a tuna sandwich every day for four weeks and 8.0 grams of boiled garlic (2.7 grams garlic powder added to boiling water) in a sandwich every day for an additional four weeks, after a 1-week washout. The ability of platelets to aggregate in PRP and whole blood will be determined before and every week after garlic consumption begins and after the 1-week washout.

Interventions

DIETARY_SUPPLEMENTgarlic powder added to ambient water

consumed 2.7 grams of garlic powder added to ambient water (equivalent to 8 grams fresh or raw garlic) in a sandwich, once a day for four weeks

DIETARY_SUPPLEMENTgarlic powder added to boiling water

consumed 2.7 grams of garlic powder added to boiling water (equivalent to 8 grams of cooked garlic) in a sandwich, once a day for four weeks

Sponsors

National Center for Complementary and Integrative Health (NCCIH)
Lead SponsorNIH

Study design

Allocation
NON_RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Body mass index of 19 to 30 kg/m2 * Plans to remain in the study area for the next year * Willingness to abstain from nonsteroidal anti-inflammatory drugs (NSAID drugs for 1 week prior to each study test * Willingness to abstain from consuming garlic and significant amounts of onion, chocolate, or purple grape juice for 3 days prior to each study test * Willingness to participate in all study tests

Exclusion criteria

* Pregnancy or breast-feeding * Serious medical condition * Allergy to garlic or wheat * Tobacco use * Excessive alcohol consumption * Under psychiatric care

Design outcomes

Primary

MeasureTime frameDescription
Percent Platelet Aggregation4 weekspercent platelet aggregation in collagen-induced platelet aggregation in platelet rich plasma (PRP)

Secondary

MeasureTime frameDescription
Electrical Impedance in Ohms4 weeksElectrical impedance (ohms) was measured using 0.5 mL of whole blood plus 0.5 mL saline in a Chronolog Whole Blood aggregometer. Ten mL of whole blood were collected and tested every week. There is no mathematical correlation between impedance (ohms) and percent aggregation.

Countries

United States

Participant flow

Recruitment details

healthy participants were recruited in Utah county, Utah, in early 2006

Participants by arm

ArmCount
Garlic Powder: High Allicin
garlic powder in ambient water
9
Garlic Powder: No Allicin
garlic powder in boiling water
6
Total15

Baseline characteristics

CharacteristicGarlic Powder: No AllicinGarlic Powder: High AllicinTotal
Age, Categorical
<=18 years
0 Participants0 Participants0.0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0.0 Participants
Age, Categorical
Between 18 and 65 years
6 Participants9 Participants15.0 Participants
Age Continuous36.5 years
STANDARD_DEVIATION 15.1
32.2 years
STANDARD_DEVIATION 13.7
32.2 years
STANDARD_DEVIATION 13.7
electrical impedance (ohms) at 0 weeks15.0 ohms
STANDARD_DEVIATION 1.6
12.7 ohms
STANDARD_DEVIATION 1.2
13.9 ohms
STANDARD_DEVIATION 1.4
percent platelet aggregation at 0 weeks71.8 percent platelet aggregation
STANDARD_DEVIATION 5.7
76.0 percent platelet aggregation
STANDARD_DEVIATION 1.6
73.9 percent platelet aggregation
STANDARD_DEVIATION 3.7
Region of Enrollment
United States
6 participants9 participants15.0 participants
Sex: Female, Male
Female
3 Participants4 Participants7.0 Participants
Sex: Female, Male
Male
3 Participants5 Participants8.0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 90 / 6
serious
Total, serious adverse events
0 / 90 / 6

Outcome results

Primary

Percent Platelet Aggregation

percent platelet aggregation in collagen-induced platelet aggregation in platelet rich plasma (PRP)

Time frame: 4 weeks

ArmMeasureValue (MEAN)Dispersion
Garlic Powder: High AllicinPercent Platelet Aggregation71.4 percent platelet aggregationStandard Deviation 4.3
Garlic Powder: No AllicinPercent Platelet Aggregation72.5 percent platelet aggregationStandard Deviation 5.5
Secondary

Electrical Impedance in Ohms

Electrical impedance (ohms) was measured using 0.5 mL of whole blood plus 0.5 mL saline in a Chronolog Whole Blood aggregometer. Ten mL of whole blood were collected and tested every week. There is no mathematical correlation between impedance (ohms) and percent aggregation.

Time frame: 4 weeks

Population: Nine persons participated in the high allicin test. Six of the same persons participated in the no allicin test.

ArmMeasureValue (MEAN)Dispersion
Garlic Powder: High AllicinElectrical Impedance in Ohms13.8 ohmsStandard Deviation 1.5
Garlic Powder: No AllicinElectrical Impedance in Ohms15.0 ohmsStandard Deviation 1.5

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026